製藥

China: Pharma heads east for profit

After 30 years of economic reform in China, the growing middle class is discovering there is more to life than working – and buying Louis Vuitton handbags.

The Chinese are becoming more likely to open their wallets to buy quality of life – and that is good news for the global healthcare industry.

In 2009, China pledged to spend Rmb850bn ($131bn) overhauling its antiquated healthcare system, which has become a focus of public dissatisfaction.

您已閱讀9%(443字),剩餘91%(4381字)包含更多重要資訊,訂閱以繼續探索完整內容,並享受更多專屬服務。
版權聲明:本文版權歸FT中文網所有,未經允許任何單位或個人不得轉載,複製或以任何其他方式使用本文全部或部分,侵權必究。
設置字型大小×
最小
較小
默認
較大
最大
分享×